PROCEPT BioRobotics Corporation
PRCTNASDAQHealthcareMedical Devices
As of Oct 23, 2026 close
- Market cap
- $1.13B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $16.67$38.11
- Volume (live)
- -
- Avg. volume (3M)
- 1.34M
PROCEPT BioRobotics (PRCT) Stock Price & Financial Analysis
PROCEPT BioRobotics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $18.75 - $20.12 |
|---|---|
| 52-Week High | $38.11 |
| 52-Week Low | $16.67 |
| Open | $19.90 |
| Volume (last close) | 773.75K |
| Average Volume (3M) | 1.34M |
| Revenue (TTM) | 337.34M |
|---|---|
| Net Income (TTM) | -109.75M |
| Free Cash Flow (TTM) | -125.97M |
| EPS (TTM) | −$1.95 |
| Profit Margin | -32.54% |
| Operating Margin | -33.86% |
| Return on Equity (ROE) | -32.27% |
| Debt to Equity | 0.16 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.13B |
|---|---|
| Shares Outstanding | 56.51M |
| Price to Sales (P/S) | 3.34 |
| Price to Book (P/B) | 3.32 |
| EV/EBITDA | -9.68 |
| 50-Day MA | $19.70 |
|---|---|
| 200-Day MA | $23.85 |
| 1-Year Change | −42.14% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
PROCEPT BioRobotics at a Glance
As of the Oct 23, 2026 close, PROCEPT BioRobotics (PRCT) has a market capitalization of $1.13B. The stock trades at 3.3× sales. Over the trailing twelve months it lost $109.75M on revenue of $337.34M and burned $125.97M of free cash flow. Revenue grew 22.7% year over year.
As of its latest reported balance sheet, it holds $227.91M in cash and securities against $54.22M of debt, a net cash position of $173.69M.
PROCEPT BioRobotics does not currently pay a dividend.
The share price is down 42.1% over the past year. At $19.96 (the Oct 23, 2026 close) it sits within its 52-week range of $16.66 to $38.11, below its 200-day moving average of $23.85.
Based on 13 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $23.10, 15.7% above the Oct 23, 2026 close.
Frequently Asked Questions About PROCEPT BioRobotics
What is the current stock price for PRCT?
As of the Oct 23, 2026 close, PRCT stock trades at $19.96. The 52-week range is $16.67–$38.11, with a day range of $18.75–$20.12.
What is the P/E ratio for PRCT?
The P/E ratio (Price-to-Earnings) for PRCT is shown in the Key Statistics section. This valuation metric helps compare PROCEPT BioRobotics Corporation to industry peers.
Does PRCT pay dividends?
PROCEPT BioRobotics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PRCT?
Based on ratings from 13 professional analysts over the last 90 days, the consensus for PRCT is Hold. The average 12-month price target is $23.10, a 15.7% upside from the Oct 23, 2026 close of $19.96.
What is the market cap of PRCT?
As of the Oct 23, 2026 close, PROCEPT BioRobotics's market capitalization is $1.13B, classifying it as a small-cap company. PROCEPT BioRobotics operates in the Healthcare sector within the Medical Devices industry.